Sign In
Buy ALBT
$0.373
+0.0039 (+1.06%)
At Close: Jun 03, 2026
Avalon GloboCare highlights the 2022 results of its latest investment, Laboratory Services MSO
10:05am, Thursday, 27'th Apr 2023
Avalon GloboCare Corp (NASDAQ:ALBT) has announced 2022 financial results for Laboratory Services MSO LLC, a clinical diagnostics and reference laboratory that Avalon acquired a 40% interest earlier th
Avalon GloboCare excited as it closes earnings accretive investment in testing firm
09:36am, Monday, 13'th Feb 2023
Avalon GloboCare Corp (NASDAQ:ALBT) has now completed its investment to take a 40% stake in drug testing firm Laboratory Services MSO (LSM). The California based investee, LSM, has a portfolio of test
Avalon GloboCare Corp (NASDAQ:ALBT) has announced that the US Patent and Trademark Office (USPTO) has issued it with US Patent No. 11,555,060, titled 'QTY Fc Fusion Water Soluble Receptor Proteins',
Avalon GloboCare appoints Lourdes Felix, CEO of a premier addiction treatment company, to its board
09:42am, Wednesday, 11'th Jan 2023
Avalon GloboCare Corp (NASDAQ:ALBT) announced that it has appointed entrepreneur and corporate finance executive Lourdes Felix to its board of directors. The Freehold, New Jersey-based biotechnolog
Avalon GloboCare reveals deployment of breakthrough fusion gene map technology
09:52am, Tuesday, 03'rd Jan 2023
Avalon GloboCare Corp (NASDAQ:ALBT) revealed that it has deployed a breakthrough fusion gene map technology to be used for the goal of developing companion diagnostic kits and devices to enhance perso
Avalon GloboCare raises $4M in Series A preferred stock to fund Laboratory Services MSO acquisition
09:42am, Wednesday, 14'th Dec 2022
Avalon GloboCare Corp (NASDAQ:ALBT) announced that it has raised $4 million through a private placement of shares of its Series A preferred stock with the company's chairman, Daniel Lu. The gross proc
